Form 4: Immunovant Director Sells Shares
Insider Transaction (Form 4)
Atul Pande, a Director of Immunovant, Inc., sold 1,500 shares of common stock on July 24, 2026 for $39.80 per share.
Summary
- Option exercise/conversion: acquired 1,500 Common Stock at $8.43 ($12,645) on July 24, 2026; holds 118,231 after (Direct).
- Open-market sale: disposed of 1,500 Common Stock at $39.80 ($59,700) on July 24, 2026; holds 116,731 after (Direct).
- Option exercise/conversion: disposed of 1,500 Stock Option (right to buy) on July 24, 2026; holds 66,681 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $59,700 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Atul Pande — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-24 | Option exercise/conversion | Common Stock | 1,500 | $8 | $12.6K | 118,231 |
| 2026-07-24 | Open-market sale | Common Stock | 1,500 | $40 | $59.7K | 116,731 |
| 2026-07-24 | Option exercise/conversion | Stock Option (right to buy) | 1,500 | — | — | 66,681 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-24 | Option exercise/conversion (1,500 shares) |
| 2026-07-24 | Open-market sale (1,500 shares) |
| 2026-07-24 | Option exercise/conversion (1,500 shares) |
Keywords
insider transaction, Form 4, IMVT, Immunovant, Inc., bearish, Atul Pande
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.